Seeking Alpha

Johnson & Johnson (JNJ) is raised to Buy from Hold with an $82 price target, up from...

Johnson & Johnson (JNJ) is raised to Buy from Hold with an $82 price target, up from $75, at Deutsche Bank, which cites improving sales trends and benefits of diversification. Recent and new drugs should continue to drive pharma sales, and JNJ should continue to work through the McNeil Consent Decree and return consumer products to market. JNJ +0.6% premarket.
Comments (1)
  • Send Email to Warren
    4 Jan 2013, 11:07 AM Reply Like
DJIA (DIA) S&P 500 (SPY)